CA1172960A - Apoglucose oxydase activee et emploi dans certains dosages par liaison competitive - Google Patents

Apoglucose oxydase activee et emploi dans certains dosages par liaison competitive

Info

Publication number: CA1172960A
Authority: CA; Canada
Prior art keywords: oxidase; antibody; binding; glucose oxidase; apoglucose
Prior art date: 1981-03-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA000396257A

Other languages

English (en)

Inventor

David L. Morris

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer Corp

Original Assignee

Miles Laboratories Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1981-03-23

Filing date

1982-02-15

Publication date

1984-08-21

1982-02-15 Application filed by Miles Laboratories Inc filed Critical Miles Laboratories Inc

1982-02-15 Priority to CA000396257A priority Critical patent/CA1172960A/fr

1984-08-21 Application granted granted Critical

1984-08-21 Publication of CA1172960A publication Critical patent/CA1172960A/fr

Status Expired legal-status Critical Current

Links

108090000854 Oxidoreductases Proteins 0.000 title claims abstract description 81
102000004316 Oxidoreductases Human genes 0.000 title claims abstract description 81
230000009870 specific binding Effects 0.000 title claims abstract description 32
238000000159 protein binding assay Methods 0.000 title claims abstract description 12
239000004366 Glucose oxidase Substances 0.000 claims abstract description 98
229940116332 glucose oxidase Drugs 0.000 claims abstract description 98
108010015776 Glucose oxidase Proteins 0.000 claims abstract description 61
235000019420 glucose oxidase Nutrition 0.000 claims abstract description 61
239000011714 flavin adenine dinucleotide Substances 0.000 claims abstract description 57
230000027455 binding Effects 0.000 claims abstract description 47
238000009739 binding Methods 0.000 claims abstract description 47
VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 claims abstract description 44
235000019162 flavin adenine dinucleotide Nutrition 0.000 claims abstract description 44
229940093632 flavin-adenine dinucleotide Drugs 0.000 claims abstract description 44
239000000126 substance Substances 0.000 claims abstract description 42
239000003446 ligand Substances 0.000 claims abstract description 41
238000000034 method Methods 0.000 claims abstract description 35
239000011541 reaction mixture Substances 0.000 claims abstract description 27
239000012634 fragment Substances 0.000 claims abstract description 20
230000000694 effects Effects 0.000 claims abstract description 12
239000003153 chemical reaction reagent Substances 0.000 claims description 29
239000000203 mixture Substances 0.000 claims description 27
239000007788 liquid Substances 0.000 claims description 15
239000000427 antigen Substances 0.000 claims description 8
102000036639 antigens Human genes 0.000 claims description 8
108091007433 antigens Proteins 0.000 claims description 8
238000003018 immunoassay Methods 0.000 claims description 4
229930024421 Adenine Natural products 0.000 claims 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims 1
AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
229960000643 adenine Drugs 0.000 claims 1
238000005065 mining Methods 0.000 claims 1
239000002773 nucleotide Substances 0.000 claims 1
230000004913 activation Effects 0.000 abstract description 16
238000003556 assay Methods 0.000 description 38
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 24
238000002835 absorbance Methods 0.000 description 21
229960000278 theophylline Drugs 0.000 description 18
239000000243 solution Substances 0.000 description 11
210000002966 serum Anatomy 0.000 description 10
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
239000000562 conjugate Substances 0.000 description 9
239000008103 glucose Substances 0.000 description 8
238000011534 incubation Methods 0.000 description 8
235000018102 proteins Nutrition 0.000 description 8
102000004169 proteins and genes Human genes 0.000 description 8
108090000623 proteins and genes Proteins 0.000 description 8
239000012064 sodium phosphate buffer Substances 0.000 description 8
108010006591 Apoenzymes Proteins 0.000 description 6
108091003079 Bovine Serum Albumin Proteins 0.000 description 6
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
230000015572 biosynthetic process Effects 0.000 description 6
229940098773 bovine serum albumin Drugs 0.000 description 6
238000005755 formation reaction Methods 0.000 description 6
LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 6
VACHUYIREGFMSP-UHFFFAOYSA-N 9,10-dihydroxyoctadecanoic acid Chemical compound CCCCCCCCC(O)C(O)CCCCCCCC(O)=O VACHUYIREGFMSP-UHFFFAOYSA-N 0.000 description 5
241000283707 Capra Species 0.000 description 5
VXPARNCTMSWSHF-DNVSUFBTSA-N Dihydrosanguinarine Natural products O=C1[C@H](C(C)=C)C[C@]2(CO)[C@@H](C)[C@H](O)CCC2=C1 VXPARNCTMSWSHF-DNVSUFBTSA-N 0.000 description 5
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 5
108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 5
102000008394 Immunoglobulin Fragments Human genes 0.000 description 5
108010021625 Immunoglobulin Fragments Proteins 0.000 description 5
229910052708 sodium Inorganic materials 0.000 description 5
239000011734 sodium Substances 0.000 description 5
RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 4
RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 description 4
102000018071 Immunoglobulin Fc Fragments Human genes 0.000 description 4
108010091135 Immunoglobulin Fc Fragments Proteins 0.000 description 4
239000002671 adjuvant Substances 0.000 description 4
229960000212 aminophenazone Drugs 0.000 description 4
239000000872 buffer Substances 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
238000008458 Glucose Oxidase Reagent Methods 0.000 description 3
108090000526 Papain Proteins 0.000 description 3
102000003992 Peroxidases Human genes 0.000 description 3
239000004365 Protease Substances 0.000 description 3
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
230000002596 correlated effect Effects 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
229940055729 papain Drugs 0.000 description 3
235000019834 papain Nutrition 0.000 description 3
108040007629 peroxidase activity proteins Proteins 0.000 description 3
229910000160 potassium phosphate Inorganic materials 0.000 description 3
235000011009 potassium phosphates Nutrition 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
238000005215 recombination Methods 0.000 description 3
230000006798 recombination Effects 0.000 description 3
102000014914 Carrier Proteins Human genes 0.000 description 2
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
108010079356 FIIa Proteins 0.000 description 2
108010001336 Horseradish Peroxidase Proteins 0.000 description 2
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
229920005654 Sephadex Polymers 0.000 description 2
239000012507 Sephadex™ Substances 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
230000003213 activating effect Effects 0.000 description 2
239000012491 analyte Substances 0.000 description 2
108091008324 binding proteins Proteins 0.000 description 2
230000008859 change Effects 0.000 description 2
230000029087 digestion Effects 0.000 description 2
231100000673 dose–response relationship Toxicity 0.000 description 2
239000008363 phosphate buffer Substances 0.000 description 2
239000011780 sodium chloride Substances 0.000 description 2
239000001488 sodium phosphate Substances 0.000 description 2
229910000162 sodium phosphate Inorganic materials 0.000 description 2
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
KXFQRJNVGBIDHA-UHFFFAOYSA-N 3,5-dichloro-2-hydroxybenzenesulfonyl chloride Chemical compound OC1=C(Cl)C=C(Cl)C=C1S(Cl)(=O)=O KXFQRJNVGBIDHA-UHFFFAOYSA-N 0.000 description 1
241000182988 Assa Species 0.000 description 1
241000700199 Cavia porcellus Species 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
241000699666 Mus <mouse, genus> Species 0.000 description 1
HRNLUBSXIHFDHP-UHFFFAOYSA-N N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide Chemical compound NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC1=NC=CC(C=2C=NC=CC=2)=N1 HRNLUBSXIHFDHP-UHFFFAOYSA-N 0.000 description 1
AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical compound IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
102000002248 Thyroxine-Binding Globulin Human genes 0.000 description 1
108010000259 Thyroxine-Binding Globulin Proteins 0.000 description 1
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
229910052921 ammonium sulfate Inorganic materials 0.000 description 1
235000011130 ammonium sulphate Nutrition 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
230000000890 antigenic effect Effects 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
229910052729 chemical element Inorganic materials 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000004737 colorimetric analysis Methods 0.000 description 1
230000000536 complexating effect Effects 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000003247 decreasing effect Effects 0.000 description 1
239000003085 diluting agent Substances 0.000 description 1
229940088598 enzyme Drugs 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
238000009396 hybridization Methods 0.000 description 1
230000007062 hydrolysis Effects 0.000 description 1
238000006460 hydrolysis reaction Methods 0.000 description 1
230000037189 immune system physiology Effects 0.000 description 1
230000000415 inactivating effect Effects 0.000 description 1
230000003993 interaction Effects 0.000 description 1
PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
239000000463 material Substances 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
235000004252 protein component Nutrition 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
NMWCVZCSJHJYFW-UHFFFAOYSA-M sodium;3,5-dichloro-2-hydroxybenzenesulfonate Chemical compound [Na+].OC1=C(Cl)C=C(Cl)C=C1S([O-])(=O)=O NMWCVZCSJHJYFW-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
210000001082 somatic cell Anatomy 0.000 description 1
241000894007 species Species 0.000 description 1
238000012421 spiking Methods 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
238000007920 subcutaneous administration Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
XUIIKFGFIJCVMT-UHFFFAOYSA-N thyroxine-binding globulin Natural products IC1=CC(CC([NH3+])C([O-])=O)=CC(I)=C1OC1=CC(I)=C(O)C(I)=C1 XUIIKFGFIJCVMT-UHFFFAOYSA-N 0.000 description 1
238000004448 titration Methods 0.000 description 1
229940035722 triiodothyronine Drugs 0.000 description 1

Landscapes

Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

CA000396257A 1981-03-23 1982-02-15 Apoglucose oxydase activee et emploi dans certains dosages par liaison competitive Expired CA1172960A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA000396257A CA1172960A (fr)	1981-03-23	1982-02-15	Apoglucose oxydase activee et emploi dans certains dosages par liaison competitive

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US24659181A	1981-03-23	1981-03-23
US246,591		1981-03-23
CA000396257A CA1172960A (fr)	1981-03-23	1982-02-15	Apoglucose oxydase activee et emploi dans certains dosages par liaison competitive

Publications (1)

Publication Number	Publication Date
CA1172960A true CA1172960A (fr)	1984-08-21

Family

ID=25669575

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA000396257A Expired CA1172960A (fr)	1981-03-23	1982-02-15	Apoglucose oxydase activee et emploi dans certains dosages par liaison competitive

Country Status (1)

Country	Link
CA (1)	CA1172960A (fr)

1982
- 1982-02-15 CA CA000396257A patent/CA1172960A/fr not_active Expired

Legal Events

Date	Code	Title	Description
2001-08-22	MKEC	Expiry (correction)
2002-02-15	MKEX	Expiry
2023-05-26	MKEX	Expiry	Effective date: 20020215

Publication	Publication Date	Title
US4493890A (en)	1985-01-15	Activated apoglucose oxidase and its use in specific binding assays
EP0782710B1 (fr)	2000-03-29	Procede pour detecter des anticorps
EP0600936B1 (fr)	1999-10-06	Affinites de liaison differentielles et methodes de detection de dissociation basees sur ces affinites
US5350674A (en)	1994-09-27	Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
US4727036A (en)	1988-02-23	Antibodies for use in determining hemoglobin A1c
US4647654A (en)	1987-03-03	Peptides useful in preparing hemoglobin A1c immunogens
US4506009A (en)	1985-03-19	Heterogeneous immunoassay method
EP0154276B1 (fr)	1991-05-08	Essai de liaison spécifique utilisant l'anti-G6PDH comme agent de marquage
EP0175560A2 (fr)	1986-03-26	Essais immunologiques utilisant des conjugués covalents d'enzymes polymérisées et d'anticorps
EP0316306A2 (fr)	1989-05-17	Anticorps monoclonaux pour l'HbA1C
AU615823B2 (en)	1991-10-10	Enzyme-linked immunoassay for measurement of cyclosporin a levels in whole blood samples
EP0256932A2 (fr)	1988-02-24	Utilisation de systèmes à l'enzyme oxidase dans des essais chimioluminescents
US4670383A (en)	1987-06-02	Immune-chemical measurement process for haptens and proteins
Imagawa et al.	1984	Evaluation of β-D-galactosidase from Escherichia coli and horseradish peroxidase as labels by sandwich enzyme immunoassay technique
JPH10511776A (ja)	1998-11-10	レセプター：遊離リガンド（リランド）複合体ならびにそれに基づくアッセイおよびキット
Cox et al.	1992	Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin
EP0061071B1 (fr)	1985-05-29	Apoglucose oxyclase activée, méthode pour sa préparation, son utilisation dans les méthodes d'essai de liaison spécifiques et moyens réactifs et trousse à réactifs la contenant
EP0088974A2 (fr)	1983-09-21	Essai immunologique homogène avec un anti-réactif marqué monoclonal
US5196349A (en)	1993-03-23	Immunoassays for thyroid hormones using thyroglobulin
Khokhar et al.	1994	Heterogeneous fluorescence immunoassays using flow-injection analysis with protein G solid phase reactors
Lee et al.	1981	A solid phase enzyme immunoassay for the quantitation of serum ferritin
CA2006474A1 (fr)	1990-06-22	Derives diphenyl geminaux et leur utilisation dans des dosages immunologiques
JPH0587809A (ja)	1993-04-06	特定タンパク質の糖化割合の測定方法
Vidžiūnaité et al.	1995	Chemiluminescent immunoassay (CLIA) for the detection of brucellosis and tularaemia antigens
KR960016337B1 (ko)	1996-12-09	샌드위치식 면역분석용 키트